WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ARWR

Based on 5 analysts offering 12 month price targets for Arrowhead Pharmaceuticals Inc

Min Forecast
$17.00-42.8%
Avg Forecast
$55.00+85.06%
Max Forecast
$80.00+169.18%

Should I buy or sell ARWR stock?

Based on 5 analysts offering ratings for Arrowhead Pharmaceuticals Inc.

Buy
Strong Buy
1 analysts 20%
Buy
3 analysts 60%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARWR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ARWR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ARWR stock forecasts and price targets.

ARWR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-02
lockedlocked$00.00+00.00%2025-08-11
lockedlocked$00.00+00.00%2025-08-08
lockedlocked$00.00+00.00%2025-05-20
lockedlocked$00.00+00.00%2025-05-13

1 of 1

Forecast return on equity

Is ARWR forecast to generate an efficient return?

Company
-56.08%
Industry
130.75%
Market
-52.16%
ARWR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARWR forecast to generate an efficient return on assets?

Company
-24.36%
Industry
47.72%
ARWR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARWR earnings per share forecast

What is ARWR's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.19
Avg 2 year Forecast
-$2.74
Avg 3 year Forecast
-$2.94

ARWR revenue forecast

What is ARWR's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$705.0M+29.3%
Avg 2 year Forecast
$397.5M-27.09%
Avg 3 year Forecast
$367.4M-32.61%
ARWR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARWR revenue growth forecast

How is ARWR forecast to perform vs Biotechnology companies and vs the US market?

Company
-17.24%
Industry
86.2%
Market
10.83%
ARWR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARWR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARWR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARWR$29.72$55.00+85.06%Buy
KRYS$143.68$195.57+36.12%Strong Buy
PCVX$32.17$91.25+183.65%Strong Buy
ACLX$76.19$119.33+56.63%Strong Buy
ACAD$23.61$30.00+27.06%Buy
View Top Biotech Stocks

Arrowhead Pharmaceuticals Stock Forecast FAQ

Is Arrowhead Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ARWR) stock is to Buy ARWR stock.

Out of 5 analysts, 1 (20%) are recommending ARWR as a Strong Buy, 3 (60%) are recommending ARWR as a Buy, 1 (20%) are recommending ARWR as a Hold, 0 (0%) are recommending ARWR as a Sell, and 0 (0%) are recommending ARWR as a Strong Sell.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.

What is ARWR's earnings growth forecast for 2025-2027?

(NASDAQ: ARWR) Arrowhead Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.29%.

Arrowhead Pharmaceuticals's earnings in 2025 is -$143,969,000.On average, 11 Wall Street analysts forecast ARWR's earnings for 2025 to be -$25,741,921, with the lowest ARWR earnings forecast at -$131,195,413, and the highest ARWR earnings forecast at $113,242,357. On average, 11 Wall Street analysts forecast ARWR's earnings for 2026 to be -$378,519,482, with the lowest ARWR earnings forecast at -$599,355,888, and the highest ARWR earnings forecast at -$114,623,361.

In 2027, ARWR is forecast to generate -$406,015,279 in earnings, with the lowest earnings forecast at -$687,740,166 and the highest earnings forecast at -$103,575,326.

What is ARWR's revenue growth forecast for 2025-2027?

(NASDAQ: ARWR) Arrowhead Pharmaceuticals's forecast annual revenue growth rate of -17.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Arrowhead Pharmaceuticals's revenue in 2025 is $545,209,000.On average, 8 Wall Street analysts forecast ARWR's revenue for 2025 to be $97,355,420,758, with the lowest ARWR revenue forecast at $75,292,357,162, and the highest ARWR revenue forecast at $108,519,321,823. On average, 8 Wall Street analysts forecast ARWR's revenue for 2026 to be $54,896,994,419, with the lowest ARWR revenue forecast at $14,044,814,240, and the highest ARWR revenue forecast at $89,323,361,358.

In 2027, ARWR is forecast to generate $50,744,038,138 in revenue, with the lowest revenue forecast at $19,154,530,335 and the highest revenue forecast at $74,933,296,031.

What is ARWR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ARWR) forecast ROA is -24.36%, which is lower than the forecast US Biotechnology industry average of 47.72%.

What is ARWR's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ARWR price target, the average ARWR price target is $55.00, with the highest ARWR stock price forecast at $80.00 and the lowest ARWR stock price forecast at $17.00.

On average, Wall Street analysts predict that Arrowhead Pharmaceuticals's share price could reach $55.00 by Sep 2, 2026. The average Arrowhead Pharmaceuticals stock price prediction forecasts a potential upside of 85.06% from the current ARWR share price of $29.72.

What is ARWR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ARWR) Arrowhead Pharmaceuticals's current Earnings Per Share (EPS) is -$1.36. On average, analysts forecast that ARWR's EPS will be -$0.19 for 2025, with the lowest EPS forecast at -$0.95, and the highest EPS forecast at $0.82. On average, analysts forecast that ARWR's EPS will be -$2.74 for 2026, with the lowest EPS forecast at -$4.34, and the highest EPS forecast at -$0.83. In 2027, ARWR's EPS is forecast to hit -$2.94 (min: -$4.98, max: -$0.75).

What is ARWR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ARWR) forecast ROE is -56.08%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.